At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 117 enrolled
Drug / intervention
Ketoprofen +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Placebo-controlled, Case-controlled, Open Label Therapeutic Trial for Unilateral or Bilateral Lymphedema of Arm or Leg.
In Brief
A Phase 4 clinical trial evaluating Ketoprofen and Placebo for Lymphedema. Completed, enrolled 117 participants across 1 site.
Detailed Summary
This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLymphedema
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
First PostedOct 2014
Primary CompletionDec 2016
Study CompletionMar 2017
TodayJul 2026
First PostedOct 7, 2014
Enrollment StartMar 1, 2009
Primary CompletionDec 1, 2016
Study CompletionMar 1, 2017
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 11.7 years ago
Interventions
Ketoprofendrug
Placebodrug
Placebo to match ketoprofen.